Development of Prodrugs for Enzyme-Mediated, Tumor-Selective Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
107-113
Author(s):
K. Jin Yoon, Philip M. Potter and Mary K. Danks
Nanotechnology on Duty in Medical Applications
Journal:
Current Pharmaceutical Biotechnology
Volume:
6
Page:
17-33
Author(s):
T. Kubik, K. Bogunia-Kubik and M. Sugisaka
Nur77 Family of Nuclear Hormone Receptors
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
413-423
Author(s):
Hui -Chen Hsu, Tong Zhou and John D. Mountz
DNA-Binding Properties of Poly(ADP-Ribose) Polymerase: A Target for Anti-Cancer Therapy
Journal:
Current Drug Targets
Volume:
5
Page:
357-365
Author(s):
V. A. Soldatenkov and V. N. Potaman
Angiogenesis: A Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
11-26
Author(s):
Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello
Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
33-43
Author(s):
Chu-Huang Chen, Simon M. Poucher, Jonathan Lu and Philip D. Henry
The Posttranslational Phase of Gene Expression: New Possibilities in Molecular Diagnosis
Journal:
Current Molecular Medicine
Volume:
3
Page:
25-38
Author(s):
J. F. Rehfeld and J. P. Goetze
Tumor Bone Diseases: Molecular Mechanisms and Opportunities for Novel Treatments
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
1
Page:
313-329
Author(s):
Mira Susa, Markus Glatt and Anna Teti